BeiGene Ltd. (49B) — Cash Flow Reinvestment Rate

Latest as of March 2025: 5.41x

BeiGene Ltd. (49B) has a Cash Flow Reinvestment Rate of 5.41x as of March 2025, reinvesting €238.35 Million (capex €116.41 Million plus investments €-121.94 Million) from operating cash flow of €44.08 Million. See how much free cash does BeiGene Ltd. generate to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

5.41x

(Capex + Investments) / Operating CF

Total Reinvested

€238.35 Million

Capex + Investments

Operating Cash Flow

€44.08 Million

EUR

Capital Expenditures

€116.41 Million

EUR

BeiGene Ltd. Cash Flow Reinvestment Rate (2017–2017)

Historical reinvestment intensity for BeiGene Ltd. across 1 annual periods. For the full cash flow conversion analysis, see BeiGene Ltd. cash flow conversion.

Annual Cash Flow Reinvestment Rate for BeiGene Ltd. (2017–2017)

Year-by-year capital reinvestment analysis for BeiGene Ltd.. See BeiGene Ltd. financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (EUR)	Operating CF	Capex	YoY Change
2017	28.54x	€363.88 Million	€12.75 Million	€46.37 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow